Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee hears reappointment hearing for Idaho Office of Drug Policy director
Summary
The Senate Judiciary and Rules Committee heard from Mary Ann King, director of the Idaho Office of Drug Policy, on her reappointment. King emphasized prevention, data-driven grants and partnerships, and warned about fentanyl and workforce shortages. The committee deferred a formal vote to the next meeting.
The Senate Judiciary and Rules Committee on Thursday heard from Mary Ann King, director of the Idaho Office of Drug Policy, at a gubernatorial reappointment hearing. King outlined her career in juvenile probation, nonprofit prevention work and her role at ODP, and described the office’s prevention-focused grant and evaluation processes.
King told the committee the agency prioritizes primary, secondary and tertiary prevention and requires applicants for community grants to document local problems, capacity and evidence-based practices. She said ODP evaluates grant outcomes and that…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
